精神分裂症护理质量指标:范围审查

IF 3.6 2区 医学 Q1 PSYCHIATRY
Jennifer C. Anderson , Dallas P. Seitz , David Crockford , Donald Addington , Hanji Baek , Diane L. Lorenzetti , Rebecca Barry , James M. Bolton , Valerie H. Taylor , Paul Kurdyak , Julia Kirkham
{"title":"精神分裂症护理质量指标:范围审查","authors":"Jennifer C. Anderson ,&nbsp;Dallas P. Seitz ,&nbsp;David Crockford ,&nbsp;Donald Addington ,&nbsp;Hanji Baek ,&nbsp;Diane L. Lorenzetti ,&nbsp;Rebecca Barry ,&nbsp;James M. Bolton ,&nbsp;Valerie H. Taylor ,&nbsp;Paul Kurdyak ,&nbsp;Julia Kirkham","doi":"10.1016/j.schres.2024.10.013","DOIUrl":null,"url":null,"abstract":"<div><div>Measuring quality of care is a critical first step towards improving the healthcare contributing to persistent poor outcomes experienced by many people living with schizophrenia. This scoping review aims to identify and characterize indicators for measuring the quality of care for people living with schizophrenia. We searched 6 academic databases, 4 grey literature databases, and 23 organization websites for documents containing quality indicators developed for or applied in a population with schizophrenia-spectrum disorders. We identified 119 unique documents, yielding 390 distinct quality indicators. Most measures were process indicators (68 %; <em>n</em> = 267) commonly reflecting safety (30 %; <em>n</em> = 118) and effectiveness (35 %; <em>n</em> = 136) domains of quality of care. Quality indicators included measures of primarily mental healthcare (77 %; <em>n</em> = 299), as well as physical healthcare (23 %; <em>n</em> = 91). Indicators reflected aspects of care related to service delivery, pharmacotherapy, assessments, resources and policies, psychological interventions, social and other interventions. Indicator development was notable for a lack of well-described validation and selection processes. Gaps in indicator availability for comorbid substance use, reproductive health, and healthcare equity were also identified. Results reflect a growing recognition of the importance of quality measurement in this population but highlight the need for prioritization of indicators to guide future quality measurement and improvement.</div></div>","PeriodicalId":21417,"journal":{"name":"Schizophrenia Research","volume":"274 ","pages":"Pages 406-416"},"PeriodicalIF":3.6000,"publicationDate":"2024-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Quality indicators for schizophrenia care: A scoping review\",\"authors\":\"Jennifer C. Anderson ,&nbsp;Dallas P. Seitz ,&nbsp;David Crockford ,&nbsp;Donald Addington ,&nbsp;Hanji Baek ,&nbsp;Diane L. Lorenzetti ,&nbsp;Rebecca Barry ,&nbsp;James M. Bolton ,&nbsp;Valerie H. Taylor ,&nbsp;Paul Kurdyak ,&nbsp;Julia Kirkham\",\"doi\":\"10.1016/j.schres.2024.10.013\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Measuring quality of care is a critical first step towards improving the healthcare contributing to persistent poor outcomes experienced by many people living with schizophrenia. This scoping review aims to identify and characterize indicators for measuring the quality of care for people living with schizophrenia. We searched 6 academic databases, 4 grey literature databases, and 23 organization websites for documents containing quality indicators developed for or applied in a population with schizophrenia-spectrum disorders. We identified 119 unique documents, yielding 390 distinct quality indicators. Most measures were process indicators (68 %; <em>n</em> = 267) commonly reflecting safety (30 %; <em>n</em> = 118) and effectiveness (35 %; <em>n</em> = 136) domains of quality of care. Quality indicators included measures of primarily mental healthcare (77 %; <em>n</em> = 299), as well as physical healthcare (23 %; <em>n</em> = 91). Indicators reflected aspects of care related to service delivery, pharmacotherapy, assessments, resources and policies, psychological interventions, social and other interventions. Indicator development was notable for a lack of well-described validation and selection processes. Gaps in indicator availability for comorbid substance use, reproductive health, and healthcare equity were also identified. Results reflect a growing recognition of the importance of quality measurement in this population but highlight the need for prioritization of indicators to guide future quality measurement and improvement.</div></div>\",\"PeriodicalId\":21417,\"journal\":{\"name\":\"Schizophrenia Research\",\"volume\":\"274 \",\"pages\":\"Pages 406-416\"},\"PeriodicalIF\":3.6000,\"publicationDate\":\"2024-10-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Schizophrenia Research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0920996424004560\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PSYCHIATRY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Schizophrenia Research","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0920996424004560","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0

摘要

衡量医疗质量是改善医疗服务的关键第一步,而医疗服务质量低下则是造成许多精神分裂症患者治疗效果持续不佳的原因之一。本范围综述旨在确定和描述衡量精神分裂症患者护理质量的指标。我们检索了 6 个学术数据库、4 个灰色文献数据库和 23 个机构网站,以查找包含为精神分裂症谱系障碍患者制定或应用的质量指标的文献。我们发现了 119 篇独特的文献,共产生了 390 个不同的质量指标。大多数指标都是过程指标(68%;n = 267),通常反映了医疗质量的安全性(30%;n = 118)和有效性(35%;n = 136)。质量指标主要包括精神医疗(77%;n = 299)和身体医疗(23%;n = 91)。指标反映了与服务提供、药物治疗、评估、资源和政策、心理干预、社会和其他干预相关的护理方面。指标制定的显著特点是缺乏完善的验证和选择过程。此外,还发现在合并药物使用、生殖健康和医疗保健公平方面的指标可用性存在差距。研究结果表明,人们日益认识到对这一人群进行质量测量的重要性,但同时也强调需要确定指标的优先次序,以指导未来的质量测量和改进工作。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Quality indicators for schizophrenia care: A scoping review
Measuring quality of care is a critical first step towards improving the healthcare contributing to persistent poor outcomes experienced by many people living with schizophrenia. This scoping review aims to identify and characterize indicators for measuring the quality of care for people living with schizophrenia. We searched 6 academic databases, 4 grey literature databases, and 23 organization websites for documents containing quality indicators developed for or applied in a population with schizophrenia-spectrum disorders. We identified 119 unique documents, yielding 390 distinct quality indicators. Most measures were process indicators (68 %; n = 267) commonly reflecting safety (30 %; n = 118) and effectiveness (35 %; n = 136) domains of quality of care. Quality indicators included measures of primarily mental healthcare (77 %; n = 299), as well as physical healthcare (23 %; n = 91). Indicators reflected aspects of care related to service delivery, pharmacotherapy, assessments, resources and policies, psychological interventions, social and other interventions. Indicator development was notable for a lack of well-described validation and selection processes. Gaps in indicator availability for comorbid substance use, reproductive health, and healthcare equity were also identified. Results reflect a growing recognition of the importance of quality measurement in this population but highlight the need for prioritization of indicators to guide future quality measurement and improvement.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Schizophrenia Research
Schizophrenia Research 医学-精神病学
CiteScore
7.50
自引率
8.90%
发文量
429
审稿时长
10.2 weeks
期刊介绍: As official journal of the Schizophrenia International Research Society (SIRS) Schizophrenia Research is THE journal of choice for international researchers and clinicians to share their work with the global schizophrenia research community. More than 6000 institutes have online or print (or both) access to this journal - the largest specialist journal in the field, with the largest readership! Schizophrenia Research''s time to first decision is as fast as 6 weeks and its publishing speed is as fast as 4 weeks until online publication (corrected proof/Article in Press) after acceptance and 14 weeks from acceptance until publication in a printed issue. The journal publishes novel papers that really contribute to understanding the biology and treatment of schizophrenic disorders; Schizophrenia Research brings together biological, clinical and psychological research in order to stimulate the synthesis of findings from all disciplines involved in improving patient outcomes in schizophrenia.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信